LGALS3BP Associates with the CCT/TRiC Chaperonin Complex and Enhances Paclitaxel Sensitivity in Triple-Negative Breast Cancer

Supplementary materials for the study entitled “LGALS3BP Associates with the CCT/TRiC Chaperonin Complex and Enhances Paclitaxel Sensitivity in Triple-Negative Breast Cancer,” including: Table SI. Complete LGALS3BP IP–MS dataset in MDA-MB-231 cells (1,159 proteins). Table SII. Proteins enriched at least fourfold relative to both controls in LGALS3BP IP–MS (146 proteins). Table SIII. LGALS3BP-associated protein lists from MDA-MB-231, HEK293, and Hepa1c1c7 cells. Figure S1. Representative DNA-content histograms after paclitaxel treatment. Figure S2. Uncropped Western blot images and bands quantified using ImageJ.